HIGHLIGHTS
- who: Issa et_al Cancer Drug and collaborators from the Department of Haematology, Aalborg University Hospital, Aalborg, Denmark have published the paper: Cancer Drug Resistance, in the Journal: (JOURNAL)
- what: The aim of this study was to develop (REGS) from dose-response assays in cultures of DLBCL and MM cell lines enabling prediction of response in DLBCL and MM patients.
- how: The authors hypothesize that bendamustine dose-response assays and GEP of cell lines can be used to find gene_expression patterns in which the expression of a group of genes predicts the cellular response . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.